Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Platelets for cancer treatment and drug delivery.
Xiao G, Zhang Z, Chen Q, Wu T, Shi W, Gan L, Liu X, Huang Y, Lv M, Zhao Y, Wu P, Zhong L, He J. Xiao G, et al. Among authors: wu t, wu p. Clin Transl Oncol. 2022 Jul;24(7):1231-1237. doi: 10.1007/s12094-021-02771-x. Epub 2022 Feb 26. Clin Transl Oncol. 2022. PMID: 35218523 Review.
Generation of αGal-enhanced bifunctional tumor vaccine.
He J, Huo Y, Zhang Z, Luo Y, Liu X, Chen Q, Wu P, Shi W, Wu T, Tang C, Wang H, Li L, Liu X, Huang Y, Zhao Y, Gan L, Wang B, Zhong L. He J, et al. Among authors: wu t, wu p. Acta Pharm Sin B. 2022 Jul;12(7):3177-3186. doi: 10.1016/j.apsb.2022.03.002. Epub 2022 Mar 9. Acta Pharm Sin B. 2022. PMID: 35865091 Free PMC article.
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study.
Ma YY, Wei ZL, Xu YJ, Shi JM, Yi H, Lai YR, Jiang EL, Wang SB, Wu T, Gao L, Gao L, Kong PY, Wen Q, Bai H, Li Y, Cao YG, Li QC, Zhang ZM, Liu BC, Su Y, Lai XY, Ma X, Cheng TT, Luo Y, Zhang X, Zhang C. Ma YY, et al. Among authors: wu t. Cancer. 2023 Jul 1;129(13):2013-2022. doi: 10.1002/cncr.34762. Epub 2023 Mar 23. Cancer. 2023. PMID: 36951498
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Among authors: wu t. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
Hepatocellular carcinoma: Advances in systemic therapies.
Wu TK, Hui RW, Mak LY, Fung J, Seto WK, Yuen MF. Wu TK, et al. F1000Res. 2024 May 7;13:104. doi: 10.12688/f1000research.145493.2. eCollection 2024. F1000Res. 2024. PMID: 38766497 Free PMC article. Review.
19,153 results
You have reached the last available page of results. Please see the User Guide for more information.